PML tumor suppressor protein is required for HCV production

被引:15
|
作者
Kuroki, Misao [1 ,2 ,3 ]
Ariumi, Yasuo [1 ,3 ]
Hijikata, Makoto [4 ]
Ikeda, Masanori [1 ]
Dansako, Hiromichi [1 ]
Wakita, Takaji [5 ]
Shimotohno, Kunitada [6 ]
Kato, Nobuyuki [1 ]
机构
[1] Okayama Univ, Dept Tumor Virol, Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan
[2] Japan Soc Promot Sci, Tokyo, Japan
[3] Kumamoto Univ, Ctr AIDS Res, Kumamoto 8600811, Japan
[4] Kyoto Univ, Dept Viral Oncol, Inst Virus Res, Kyoto 6068507, Japan
[5] Natl Inst Infect Dis, Dept Virol 2, Tokyo 1628640, Japan
[6] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Ichikawa, Chiba 2728516, Japan
基金
日本学术振兴会;
关键词
Hepatitis C virus; PML; INI1; DDX5; Tumor suppressor; Lipid droplet; HEPATITIS-C-VIRUS; NUCLEAR-BODIES; CELL-CULTURE; TRANS-ENCAPSIDATION; LENTIVIRAL VECTOR; MAMMALIAN-CELLS; RNA REPLICATION; GENE DELIVERY; IN-VIVO; GENOME;
D O I
10.1016/j.bbrc.2012.11.108
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
PML tumor suppressor protein, which forms discrete nuclear structures termed PML-nuclear bodies, has been associated with several cellular functions, including cell proliferation, apoptosis and antiviral defense. Recently, it was reported that the HCV core protein colocalizes with PML in PML-NBs and abrogates the PML function through interaction with PML. However, role(s) of PML in HCV life cycle is unknown. To test whether or not PML affects HCV life cycle, we examined the level of secreted HCV core and the infectivity of HCV in the culture supernatants as well as the level of HCV RNA in HuH-7-derived RSc cells, in which HCV-JFH1 can infect and efficiently replicate, stably expressing short hairpin RNA targeted to PML. In this context, the level of secreted HCV core and the infectivity in the supernatants from PML knockdown cells was remarkably reduced, whereas the level of HCV RNA in the PML knockdown cells was not significantly affected in spite of very effective knockdown of PML. In fact, we showed that PML is unrelated to HCV RNA replication using the subgenomic HCV-JFH1 replicon RNA, JRN/3-5B. Furthermore, the infectivity of HCV-like particle in the culture supernatants was significantly reduced in PML knockdown JRN/3-5B cells expressing core to NS2 coding region of HCV-JFH1 genome using the trans-packaging system. Finally, we also demonstrated that INI1 and DDX5, the PML-related proteins, are involved in HCV production. Taken together, these findings suggest that PML is required for HCV production. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:592 / 597
页数:6
相关论文
共 50 条
  • [31] Loss of the tumor suppressor PML in human cancers of multiple histologic origins
    Gurrieri, C
    Capodieci, P
    Bernardi, R
    Scaglioni, PP
    Nafa, K
    Rush, LJ
    Verbel, DA
    Cordon-Cardo, C
    Pandoli, PP
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (04): : 269 - 279
  • [32] Loss of the tumor suppressor PML in tumors of multiple histological origins.
    Gurrieri, C
    Capodieci, P
    Nafa, K
    Gerald, WL
    Cordon-Cardo, C
    Pandolfi, PP
    BLOOD, 2001, 98 (11) : 94A - 95A
  • [33] E6AP promotes the degradation of the PML tumor suppressor
    I Louria-Hayon
    O Alsheich-Bartok
    Y Levav-Cohen
    I Silberman
    M Berger
    T Grossman
    K Matentzoglu
    Y-H Jiang
    S Muller
    M Scheffner
    S Haupt
    Y Haupt
    Cell Death & Differentiation, 2009, 16 : 1156 - 1166
  • [34] Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates
    Liebl, Magdalena C.
    Hofmann, Thomas G.
    CANCERS, 2022, 14 (19)
  • [35] PML-DEFICIENCY DETERMINES LIVER TUMOR DEVELOPMENT IN CHRONIC HCV INFECTION
    Herzer, Kerstin
    Carbow, Anna
    Weyer, Sandra
    Kanzler, Stephan
    Biesterfeld, Stefan
    Galle, Peter R.
    HEPATOLOGY, 2009, 50 (04) : 930A - 931A
  • [36] PML-RARα alleviates the transcriptional repression mediated by tumor suppressor Rb
    Khan, MM
    Nomura, T
    Kim, H
    Kaul, SC
    Wadhwa, R
    Zhong, S
    Pandolfi, PP
    Ishi, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (47) : 43491 - 43494
  • [37] Mutations of the PML tumor suppressor gene in RA-resistant APL.
    Gurrieri, C
    Nafa, K
    Taha, M
    Jain, V
    Douer, D
    Biondi, A
    Nimer, S
    Gallagher, R
    Pandolfi, PP
    BLOOD, 2001, 98 (11) : 835A - 835A
  • [38] Merlin sumoylation is required for its tumor suppressor activity
    Qi, Q.
    Liu, X.
    Brat, D. J.
    Ye, K.
    ONCOGENE, 2014, 33 (41) : 4893 - 4903
  • [39] Identification of GeMAC as a tumor suppressor required for genomic stability
    Li, Zheng
    Zhang, Qian
    Mao, Jian-Hua
    Ho, Linus
    Balmain, Allan
    Cai, Wei-Wen
    CANCER RESEARCH, 2006, 66 (08)
  • [40] Merlin sumoylation is required for its tumor suppressor activity
    Q Qi
    X Liu
    D J Brat
    K Ye
    Oncogene, 2014, 33 : 4893 - 4903